A

Avenue Therapeutics
D

ATXI

1.78000
USD
-0.03
(-1.66%)
Market Closed
Volume
0
EPS
-20
Div Yield
-
P/E
0
Market Cap
3,655,983
OverviewSignalsIdeasNews
Related Instruments
    A
    AGIO
    -0.380
    (-1.06%)
    35.390 USD
    A
    ARWR
    -0.020
    (-0.10%)
    19.450 USD
    G
    GLYC
    0.03380
    (16.81%)
    0.23490 USD
    I
    INCY
    1.910
    (2.85%)
    68.910 USD
    K
    KPTI
    0.00170
    (0.26%)
    0.64430 USD
    M
    MGNX
    0.01000
    (0.31%)
    3.19000 USD
    R
    RARE
    0.770
    (1.77%)
    44.190 USD
    S
    SRPT
    -0.470
    (-0.39%)
    118.970 USD
    U
    UTHR
    -0.43
    (-0.12%)
    359.33 USD
    X
    XLRN
    0
    (0%)
    0.000000 USD
    More
News

Title: Avenue Therapeutics

Sector: Healthcare
Industry: Biotechnology
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It focuses on developing its product candidate, AJ201, for spinal and bulbar muscular atrophy, BAER-101, for the treatment of epilepsy and panic disorders, and IV Tramadol for the management of moderate-to-moderately-severe pain in adults.